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Abstract
Background: Wolfram syndrome gene 1 (WFS1) accounts for most of the familial nonsyndromic
low-frequency sensorineural hearing loss (LFSNHL) which is characterized by sensorineural
hearing losses equal to and below 2000 Hz. The current study aimed to contribute to our
understanding of the molecular basis of LFSNHL in an affected Taiwanese family.
Methods: The Taiwanese family with LFSNHL was phenotypically characterized using audiologic
examination and pedigree analysis. Genetic characterization was performed by direct sequencing
of WFS1 and mutation analysis.
Results: Pure tone audiometry confirmed that the family members affected with LFSNHL had a
bilateral sensorineural hearing loss equal to or below 2000 Hz. The hearing loss threshold of the
affected members showed no progression, a characteristic that was consistent with a mutation in
the  WFS1  gene located in the DFNA6/14/38 locus. Pedigree analysis showed a hereditarily
autosomal dominant pattern characterized by a full penetrance. Among several polymorphisms, a
missense mutation Y669H (2005T>C) in exon 8 of WFS1 was identified in members of a Taiwanese
family diagnosed with LFSNHL but not in any of the control subjects.
Conclusion: We discovered a novel heterozygous missense mutation in exon 8 of WFS1 (i.e.,
Y669H) which is likely responsible for the LFSNHL phenotype in this particular Taiwanese family.
Background
Severe hearing impairment affects 1 in 1000 newborns
and will in a significant percentage of this population lead
to a delayed speech and language development. Heredi-
tary hearing loss may be associated with other clinical dis-
orders and coexist with other organ malformations
(syndromic), or may be the only disease phenotype (non-
syndromic). Approximately 70% of hereditary deafness is
non-syndromic, of which ~80% is categorized as auto-
somal recessive (DFNB), ~15–20% as autosomal domi-
nant (DFNA), ~1% as X-linked (DFN), and ~≥1% as
mitochondrial or chromosome aberrations [1]. To date,
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over 90 different loci correlated with the non-syndromic
disease have been mapped [2]. Thirty-nine genes underly-
ing non-syndromic hearing impairment have been identi-
fied and more than a dozen genes involved in syndromic
deafness have also been uncovered [3].
Autosomal dominant non-syndromic low frequency sen-
sorineural hearing loss (LFSNHL; OMIM #600965) is a
unique phenotype of hearing impairment affecting the
low frequencies (i.e., 2000 Hz and below) [4]. Although
over 50 loci have been mapped in various types of DFNA
cases, to date, only three chromosomal loci have been
associated with LFSNHL (i.e., 5q31 (DFNA1), 4p16
(DFNA6/14/38), and 5q31 between D5S1972 and
D5S410 (DFNA54)) [2,5]. Two genes, namely the Homo
sapiens diaphanous homolog 1 gene (DIAPH1) related to
DFNA1 and the Wolfram syndrome 1 gene (WFS1), have
been shown to be involved in LFSNHL [6,7]. WSF1
encodes wolframin, a hydrophobic transmembrane pro-
tein that is related to LFSNHL associated with DFNA6/14/
38 [8,9]. Although the loci DFNA1, DFNA6/14/38, and
DFNA54 are associated with LFSNHL, the progression of
hearing impairment caused by a mutation in either of
these three loci exhibits different characteristics. Patients
carrying a mutation in the DFNA1 locus typically experi-
ence a rapidly deteriorating hearing impairment spread-
ing from low to all higher frequencies [10]. In contrast,
patients carrying a mutation in the DFNA54 or DFNA6/
14/38 locus experience deafness propagating from low to
high frequencies [5] or have no or mild progression
beyond the presbycusis [4,9,11], respectively.
In this study, we have examined a Taiwanese family
affected by non-progressive LFSNHL and identified a
novel mutation in the WFS1 gene (i.e., Y669H) which is
most likely correlated with LFSNHL as this mutation was
not observed in any of the numerous control subjects with
normal hearing abilities who were examined herein.
Methods
Subjects and audiometric examination
A Taiwanese family comprised of 10 individuals, includ-
ing three members diagnosed with LFSNHL, was exam-
ined. After signing the informed consent, family members
received a medical survey, including otorhinolaryngologic
examination, especially otoscopy. Based on the medical
history of the subjects tested herein, syndromic and/or
environmental deafness could be excluded based on the
review of the medical history (data not shown). Unrelated
control subjects exhibited no symptomatic signs of audi-
tory and/or vestibular impairment, based on their medical
history and physical examination, including pure tone
audiometry (GSI 17 portable audiometer, (Grason-Sta-
dler, Inc., Madison, WI, USA).
DNA extraction
Genomic DNA was extracted from 4 ml whole blood or
buccal epithelial cells using the GFX™ Genomic Blood
DNA Purification Kit (Amersham Biosciences) and stored
at -20°C until used.
Primer design and PCR amplification
Coding and flanking intron sequences of exons 2 to 8 of
the WFS1 gene (GenBank accession number AC004599)
were amplified by PCR using 13 primer pairs (Table 1).
PCR reactions were performed in a 50-µL volume contain-
ing 100–500 ng DNA, 0.2 µM of each forward and reverse
primer, 200 µM dNTPs, 1× PCR buffer (10 mM Tris-HCl
Table 1: Primers used in PCR/sequencing reaction of WFS1 coding region*
Primer sequence
Fragment Forward primer (5-3) Reverse primer (5-3)
Exon 2† AAGCGGTGCTGGCCCATG CCGTTCCCACCCAGCTATC
Exon 3† TACTCCTGGCCTGGATTTGA CATGGGCACCCTACCAACA
Exon 4† AGTGGCCGGAGGCTCAGT CCAACAGCATCACCAGCGT
Exon 5† AGTCAGATGTCCATGCATCC CTCTACAGGAAGGTTCTGGT
Exon 6† GAGCACGCTACGTGGTGCT GGAGGCACGGGTGAGATAG
Exon 7† CCTGAACCCACTCAGCTC CCAGCGGCACGGCTGTAA
Exon 8-1§ TTCCCACGTACCATCTTTCC CACATCCAGGTTGGGCTC
Exon 8-2§ AGAACTTCCGCACCCTCAC TCAGGTAGGGCCAATTCAAG
Exon 8-3§ CTATCGCTGCTGCCCTCC GGGCAAAGAGGAAGAGGAAG
Exon 8-4§ GTGAGCTCTCCGTGGTCATC CCCTCTGAGCGGTACACATAG
Exon 8-5§ ATCCTGGTGTGGCTCACG GTAGAGGCAGCGCATCCAG
Exon 8-6§ GCGTGACTGACATCGACAAC GCTGAACTCGATGAGGCTG
Exon 8-7§ CAGCAGCGAGTTCAAGAGC CCTCATGGCAACATGCAC
*WFS1 sequence based on the GenBank entry (accession number: AC004599).
†Primers were designed and synthesized herein (Methods).
§Primers were provided by Dr. Yann-Jinn Lee.BMC Medical Genetics 2007, 8:26 http://www.biomedcentral.com/1471-2350/8/26
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pH 8.3, 50 mM KCl, 2.5 mM MgCl2), and 0.5 U of Ampl-
iTaq Gold™ DNA Polymerase (Applied Biosystems, Foster
City, CA, USA). PCR amplifications were performed in a
Gene Amp PCR System 9700 (Applied Biosystems) with
an initial denaturation step at 95°C for 10 min and then
36 cycles at 95°C for 30 s, 60°C for 30 s, 72°C for 45 s,
followed by 7 min of final extension at 72°C. In case of
exon 8, amplifications were performed for 30 cycles at an
annealing temperature of 58°C.
Direct sequencing
A 10-µL sequencing reaction was performed with 100 ng
of the purified PCR product as a template, 30 pmol of
each of the sequencing primers, and 1 µL of the BigDye
Terminator v3.0 Sequencing Ready Reaction Cycle
sequencing kit (Applied Biosystems). After completion of
the reaction, the mixture was purified by gel filtration on
a Sephadex G-50 column (Amersham Pharmacia Biotech,
Piscataway, NJ, USA). Bidirectional sequencing was ana-
lyzed on an automated ABI Prism 377-18 DNA sequencer
(Applied Biosystems).
PCR-RFLP analysis
A PCR-based restriction fragment length polymorphism
(RFLP) assay was used to detect the 1235 T>C and 2005
T>C nucleotide changes. The 672-bp PCR product ampli-
fied by PCR using the forward primer (5'-TTC CCA CGT
ACC ATC TTT CC-3') and the reverse primer (5'-CAC ATC
CAG GTT GGG CTC-3') contained a polymorphic restric-
tion site at position 1235. Amplification was performed as
described above and PCR products were analyzed by 2%
agarose gel electrophoresis. PCR products (3 µL) were
digested with 7 U of restriction enzyme BbsI (New Eng-
land Biolabs, Ipswich, MA, USA) in a final volume of 10
µL and fragments were separated on a 2% agarose gel.
The 154-bp PCR product with the polymorphic restriction
site at position 2005 was amplified by PCR using forward
primer 5'-GTC AAG CTC ATC CTG GTG TG-3' and reverse
primer 5'-CCA TGT TGG TCT CCT TCC AG-3'. PCR ampli-
fication was performed as described above. After verifica-
tion of the PCR products on agarose gel, 3 µL was used to
digest with 7.5 U of NlaIII (New England Biolabs) in a
final volume of 10 µL and fragments were separated on a
4% agarose gel.
Results
Characteristic hearing impairment in family members 
affected with LFSNHL
The Taiwanese family examined herein showed an auto-
somal dominant hereditary pattern with a full penetrance,
which strongly suggests that an underlying genetic factor
is involved (Figure 1). Three affected members (I:2, II:1,
and II:3) had a characteristic LFSNHL and did not wear
hearing aids. Audiograms of the affected members
showed a bilateral average hearing of 40–60 dB at the fre-
quencies of 0.25, 0.5, 1, and 2 kHz and a normal hearing
threshold at 4 and 8 kHz (Figure 1).
The hearing loss threshold of the mother (I:2, age 56) and
her affected daughters (II:1, age 36; and II:3, age 22)
showed nearly no progression based on a comparison of
symptoms between the mother and her daughters. The
latter is characteristic for a mutation in the DFNA6/14/38
locus of WFS1 (Figure 1).
Identification of a novel mutation in the WFS1 gene in 
family members with LFSNHL
Four non-synonymous nucleotide changes were identi-
fied by direct sequencing of the WFS1  gene coding
sequence (exon 2–8) in the three affected individuals.
Two of these changes (1832A>G and 2158A>G) were
ruled out by phenotype-genotype comparisons within the
family, whereas the other two non-synonymous changes
(1235T>C and 2005A>C) were potential candidate muta-
tions.
Though 1235T>C had been reported as polymorphism
based on study of Japanese society, we compared the RFLP
Pedigree of the family affected with LFSNHL and audiogram  of three chosen affected individuals Figure 1
Pedigree of the family affected with LFSNHL and audiogram 
of three chosen affected individuals. In the pedigree, shaded 
symbols indicate family members affected by LFSNHL, while 
open symbols indicate those with a normal hearing. An auto-
somal dominant hereditary pattern is shown in this pedigree. 
Pure tone audiograms of I:2, II:1, and II:3 show a predomi-
nantly bilateral low-tone hearing impairment. Circles and 
crosses indicate air conduction in the right and left ears 
respectively.BMC Medical Genetics 2007, 8:26 http://www.biomedcentral.com/1471-2350/8/26
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pattern of the family members with that of 100 unrelated
controls possessed of Taiwanese genetic background and
normal pure tone audiograms [12]. The controls were
screened for the occurrence of mutations of interest based
on the RFLP assays. The three family members affected
with LFSNHL and 1 out of 100 controls (200 chromo-
somes) had the same RFLP pattern after digestion of the
amplicons by BbsI in position 1235 (Figure 2a). The pres-
ence of this polymorphism was attributed to a 1235T>C
mutation. However, the RFLP pattern of none of the 100
controls (200 chromosomes) was identical to that of any
of the affected family members upon digestion of ampli-
cons with NlaIII at position 2005 (Figure 2b), strongly
suggesting that the 2005T>C, but not the 1235T>C muta-
tion, is related to the symptoms observed among the fam-
ily members.
This demonstrates that we have identified a novel hetero-
zygous mutation 2005T>C in exon 8, which predicts a
Y669H alteration (Figure 3). This mutation was found in
all the affected members of this family that exhibited LFS-
NHL (Figure 2c), but not in any of the control subjects,
nor was it present in the respective WFS1 gene products of
Mus sp. and Rattus sp. (Figure 3). This particular genetic
region of the WFS1  gene product is highly conserved
among healthy humans, Mus sp., and Rattus sp. (Figure 3).
Discussion
We have identified a novel mutation in the WFS1 gene
(i.e., Y669H) in a Taiwanese family whose members were
likely diagnosed with LFSNHL, although other diagnoses
could not be excluded with certainty. Homozygous or
compound heterozygous mutations in WFS1 may lead to
(a) RFLP of the BbsI-digested PCR fragments flanking the 1235T>C region for the family affected by LFSNHL and one normal  control Figure 2
(a) RFLP of the BbsI-digested PCR fragments flanking the 1235T>C region for the family affected by LFSNHL and one normal 
control. The 672-bp PCR product obtained using the forward primer (5'-TTC CCA CGT ACC ATC TTT CC-3') and the 
reverse primer (5'-CAC ATC CAG GTT GGG CTC-3') contains a polymorphic restriction site at position 1235. Two frag-
ments of 455 bp and 217 bp from genotype TT were unaffected by enzyme digestion, while three fragments of 672 bp (solid 
arrow), 455 bp, and 217 bp were observed from heterozygotes carrying genotype TC as I:2, II:1, II:3 and one normal control 
(C indicated by the open arrow). M: DNA marker. (b) RFLP of NlaIII digested the fragment flanking the 2005T>C region of 
LFSNHL family members and normal controls. The 154-bp PCR product of the polymorphic restriction site at position 2005 
was amplified by PCR using the forward primer (5'-GTC AAG CTC ATC CTG GTG TG-3') and reverse primer (5'-CCA TGT 
TGG TCT CCT TCC AG-3'). Genotype TT such as unaffected individuals and controls (C1, C2, C3 and C4) demonstrated 
two fragments of 78 and 75 bp, whereas the heterozygote TC such as I:2, II:1, and II:3 showed 4 fragments of 78, 75, 41 (solid 
arrow), and 37 bp (solid arrow). In all samples, the enzyme also generated a fragment of 1 bp, which was too small to be seen 
in the gel. U: undigested control, M: DNA marker. (c) Electrophoregrams of WFS1 gene sequences flanking position 2005 of 
the affected and unaffected family members. The affected family members are heterozygote (T and C) in position 2005 (labeled 
with a star), while the unaffected family members are homozygous as T in the same place.BMC Medical Genetics 2007, 8:26 http://www.biomedcentral.com/1471-2350/8/26
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the autosomal recessive inherited Wolfram syndrome,
presenting a variety of phenotypes, including diabetes
insipidus, diabetes mellitus, optic atrophy, and deafness,
referred to as DIDMOAD (OMIM:#222300) [13]. Audio-
grams of patients diagnosed with Wolfram syndrome typ-
ically show hearing impairment involving the middle and
high frequencies [14]. In contrast, heterozygous muta-
tions in WFS1 clustered in the C-terminal domain affect
the low frequency component of human audiogram [15].
These characteristics are consistent with those presented
by the affected subjects of the Taiwanese family studied
herein, i.e. low pitch deterioration and the occurrence of
a Y669H mutation in the C-terminal region of WFS1.
Interestingly, a Y669C mutation has been observed in a
Wolfram syndrome patient [13]. Therefore, it is likely that
the C-terminal domain of WFS1 be involved in tonotopic
arrangement. However, the role of wolframin and its
implication in the etiology of LFSNHL in humans is still
unclear. It has been suggested that wolframin could be
involved in proper ion transport in the inner ear [16].
The identification of the Y669H mutation in the WFS1
gene product of members of the Taiwanese family with
symptoms of LFSNHL, the absence of this mutation in
control subjects with a normal hearing ability, and the
degree of conservation of Y669 in the WFS1 protein of
human, mouse, and rat supports our interpretation that
the Y669H mutation is causative. A recent examination of
a Danish family revealed a clinical spectrum with consid-
erable overlap between classical Wolfram syndrome and
non-syndromic LFSNHL [17]. Unfortunately, due to a
limited clinical history of the Taiwanese family members
lacking endocrinological, ophthalmological, and psychi-
atric analyses, it is at present impossible to verify whether
the symptoms of the subjects studied herein resemble
those related to this clinical spectrum. In addition, one
should consider that a mutation in one gene may produce
multiple phenotypes (allelism) and that a mutation in the
same allele may produce different hearing loss character-
istics in different families (pleiotropic effect). Further-
more, a recent report strongly suggests that the phenotypic
outcome of a particular mutation in a genetic region that
causes an improper functioning of the hearing apparatus
may be influenced by modifier genes that affect for
instance disease penetrance and progression. In other
words, the same mutation may lead to a considerably dif-
ferent phenotype in two distinct families as each individ-
ual is born with a unique complement of modifier genes
[18]. Thus, in order to link with certainty the Y669H
mutation in WFS1  with symptoms of LFSNHL, future
research will involve the construction of a transgenic
mouse model carrying this mutation and the analysis of
its phenotypic behavior, particularly in respect to symp-
toms of hearing impairment.
Conclusion
Phenotypic and genetic characterization of a Taiwanese
family affected with LFSNHL revealed a novel missense
mutation in WFS1 (i.e., 2005A>C; Y669H) which was not
observed in any of the examined healthy control subjects.
The molecular diagnosis of this family may provide new
insights for genetic counseling of families affected with
hearing loss and may help to solve the molecular basis of
hearing impairment. Evaluation of other affected family
members and other unrelated LFSNHL families may help
to uncover new WFS1 mutations and polymorphisms and
help to decipher the role of wolframin in auditory func-
tions.
Abbreviations
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restriction fragment length polymorphism; WFS1, Wolf-
ram syndrome gene 1.
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